BOCK

General

Calf Botox Slims the Calf Modestly. Satisfaction Depends on the Fat Above the Muscle.

Edgar Degas spent much of his career in the rehearsal rooms of the Paris Opera, drawing and painting dancers as they stretched, waited and practised. The legs in those pictures are rarely the subject. They are the machinery that makes everything else in the picture possible, and Degas drew them as working parts, not as a problem to be solved.

Patients come to me with the opposite view of their own legs. They ask about calf Botox, also called a calf reduction injection or treatment for gastrocnemius hypertrophy, because the muscle at the back of the lower leg looks too heavy for the skirts and trousers they want to wear. Botulinum toxin blocks the signal a nerve sends to a muscle, and a muscle that receives less signal is used less and gets thinner over time. In the best-controlled trial here, calf circumference fell by only a small amount, and how pleased patients were seems to depend on the thickness of the fat above the muscle. Three papers carry the case: a 2024 randomized trial in Plastic and Reconstructive Surgery Global Open, a 2024 study of 50 patients in Plastic and Reconstructive Surgery, and a 2020 review in Dermatologic Surgery.


How much does calf Botox reduce calf size?

In a randomized, double-blind trial, the maximum circumference of the calf fell from 36.35 cm to 35.87 cm eight weeks after injection (P = 0.03) (Han et al., 2024). That is a change of about half a centimetre. The trial enrolled 20 patients (40 legs, aged 21 to 51), and each leg was randomly assigned to 60 or 100 units of botulinum toxin type A, given at 20 points across the thickest part of the calf (Han et al., 2024).

Half a centimetre is real on a tape measure and small in a mirror. The trial compared two doses and had no placebo or untreated leg, so it cannot say how much of the change was caused by the injection alone (Han et al., 2024).


Does a higher dose shrink the calf more?

Not in this trial: 100 units did no better than 60 units (Han et al., 2024). Circumference changed by −0.52 ± 0.74 cm in the 60-unit legs and −0.44 ± 1.04 cm in the 100-unit legs (P = 0.78), which is −1.46% against −1.10% (P = 0.64). Satisfaction on a 1 to 5 scale was 3.9 ± 0.68 with 60 units and 4.5 ± 0.97 with 100 units, a difference that was not statistically significant (P = 0.17) (Han et al., 2024).

The authors list their own limits: a small study at a single centre, follow-up of eight weeks, circumference as the only objective measure, and only two dose groups (Han et al., 2024). The research was funded by the manufacturer of the toxin used (Han et al., 2024). A trial this small can miss a real difference between doses, so "no significant difference" is not the same as "no difference".


Why are some patients satisfied and others not?

In a study of 50 patients, satisfaction followed a U-shaped pattern: the patients with the thinnest and the thickest layers of fat above the calf muscle were more satisfied than those in between (Xu et al., 2024). The investigators measured the maximal leg circumference and used B-mode ultrasound (the same kind of scan used for pregnancy checks) to measure the thickness of the gastrocnemius and of the subcutaneous fat. They sorted the 50 cases into slim (under 0.55 cm), moderate (0.55 to 0.85 cm) and bulge (over 0.85 cm) fat groups. Every patient received 300 units of botulinum toxin type A and was followed at 1 and 6 months (Xu et al., 2024).

Patients in the slim and bulge groups reported higher satisfaction with calf contour than those in the moderate group, and 100% of both the slim and bulge groups were completely satisfied with calf contour at 6 months (Xu et al., 2024). Satisfaction with the improvement in total leg circumference was low in all three groups. No severe complications were reported (Xu et al., 2024).

The authors conclude that pre-procedure conversations matter in treating gastrocnemius hypertrophy (Xu et al., 2024). I read that as a plain message: the injection acts on the muscle, and what the patient sees also includes what lies above it.


What do reviews say about safety and dose?

A 2020 literature review concluded that botulinum toxin for calf reduction is an emerging, noninvasive option that looks efficacious with few immediate side effects, based on limited publications (Cheng et al., 2020). The review covered injection technique, expected efficacy, outcome monitoring and side effects, and it named three gaps: criteria for defining calf hypertrophy, the minimum effective dose, and the possible long-term effects of injections (Cheng et al., 2020).

The two newer papers fit that picture. No complications were observed in the randomized trial (Han et al., 2024), and no severe complications were encountered in the 50-patient study (Xu et al., 2024). Those are small studies with short follow-up, so the absence of serious events is not proof of safety.


The strongest objection

Some will say a reduction that is statistically significant is a result, and that patients in the 50-patient study were happy with their contour. That is partly true. The change in the randomized trial had a P value of 0.03, and complete satisfaction with contour was reported in two of the three fat groups (Han et al., 2024; Xu et al., 2024).

But the trial followed legs for eight weeks and had no untreated comparison (Han et al., 2024). The satisfaction study reported low satisfaction with total leg circumference in every group (Xu et al., 2024). The review is built on limited publications and says the minimum effective dose is still unknown (Cheng et al., 2020). The evidence supports a modest effect on a tape measure. It does not yet support a promise about how much smaller a particular calf will look.


What should you ask before calf Botox?

Ask first whether your calf is bulky because of muscle, and how that was checked. The studies measured muscle and fat thickness with ultrasound before treating (Xu et al., 2024), which is a reasonable standard to expect. Then ask what change to expect in circumference and in contour, because the two outcomes were not the same in the satisfaction study (Xu et al., 2024).

Ask about the dose and why it was chosen. The papers used 60 units, 100 units and 300 units, in different designs, and no agreed dose exists (Cheng et al., 2020; Han et al., 2024; Xu et al., 2024). Finally, ask how long results have been followed. The longest follow-up here was 6 months (Xu et al., 2024).


The Clinical Bottom Line

Calf Botox is a reasonable option for a patient whose calf bulk is muscle and who wants a modest change in contour. Circumference fell by about half a centimetre at 8 weeks in the one randomized trial (Han et al., 2024), a higher dose did not do better in that trial (Han et al., 2024), and complications were not severe in the studies here (Han et al., 2024; Xu et al., 2024).

The caution is about expectations. The fat layer above the muscle was linked to satisfaction in a U-shaped pattern, and satisfaction with total leg circumference was low in every group (Xu et al., 2024). There is no placebo-controlled trial, no agreed dose, and follow-up of no more than 6 months. The honest promise is a modest, measurable change, not a different leg.

Degas drew the dancer's leg as machinery, not as a problem. A calf treated with botulinum toxin runs a little lighter, and how much lighter it feels depends on what lies above the muscle.

For clinical assessments and consultation in Seoul: itsdrbock.com


References

Cheng, J., Chung, H. J., Friedland, M., & Hsu, S. H. (2020). Botulinum toxin injections for leg contouring in East Asians. Dermatologic Surgery, 46(Suppl. 1), S62–S70. https://doi.org/10.1097/DSS.0000000000002320

Han, W. Y., Lee, Y. S., & Han, H. H. (2024). The efficacy of botulinum toxin A injection for gastrocnemius hypertrophy: A prospective, randomized, double-blinded controlled trial. Plastic and Reconstructive Surgery Global Open, 12(5), Article e5813. https://doi.org/10.1097/GOX.0000000000005813

Xu, X., Liu, D., Wu, M., Luo, L., Feng, J., Ou, Y., Kang, Y., Panayi, A. C., Long, Y., & Cui, Y. (2024). The effect of calf subcutaneous fat thickness on patient satisfaction after calf contouring with botulinum toxin A. Plastic and Reconstructive Surgery, 154(1), 63e–69e. https://doi.org/10.1097/PRS.0000000000010721

More From the Blog